HIGHLIGHTS
- who: Patrizia Chiusolo from the University of Rome Tor Vergata, Italy have published the article: Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients, in the Journal: (JOURNAL) of April/28,/2021
- what: In fact, one of the main goals of MRD assessment is to identify, as early as possible the subset of patients at risk of relapse, despite being in CR. The aim of the study was to evaluate a greater predictivity of WT1 expression in CD34 + cells as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.